Postprandial Blood Glucose Level in Maintenance Hemodialysis Patients Predicts Post-transplant-Diabetes-mellitus

Abstract

Post-transplant-diabetes-mellitus (PTDM) is a frequent complication after kidney transplantation. One-hundred-and-seven patients with kidney transplantation were screened for the occurrence of PTDM. Of these, full data sets from 49 subjects were available with documented glucose concentrations during maintenance hemodialysis (MHD) and regular clinical follow-up of 7–34 months. For assessment of glucose metabolism the response to a standard meal during MHD was used in normoglycemic patients based on fasting blood glucose. Abnormal postprandial blood glucose concentration was defined as >140 mg/dl 2 h after food intake.Twelve end stage renal disease patients had abnormal postprandial blood glucose on MHD. All 12 subjects but also four MHD patients with normal postprandial and fasting blood glucose values developed PTDM. Multivariate Cox-regression analysis revealed that abnormal postprandial blood glucose is a strong predictor for PTDM (Hazard ratio: 42.3 (IQR: 7.9–227.2); p<0.001). Fasting blood glucose (94 vs. 100 mg/dl) was not different between MHD patients who did (n=16) or did not (n=33) develop PTDM.This study suggests that measurement of postprandial blood glucose during MHD identifies patients who develop PTDM after kidney transplantation. It should be used for screening of patients at risk.

Key words

PTDM - hemodialysis - postprandial glucose

References

• 1 Salvadori M, Bertoni E, Rosati A. et al . Post-transplant diabetes mellitus.  J Nephrol. 2003;  16 626-634
• 2 Pavlakis M. New-onset diabetes after transplantation.  Curr Diab Rep. 2005;  5 300-304
• 3 van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus.  Nephrol Dial Transplant. 2004;  19 ((Suppl 6)) vi8-12
• 4 Erlinger TP, Brancati FL. Postchallenge hyperglycemia in a national sample of US with type 2 diabetes.  Diabetes Care. 2001;  24 1734-1738
• 5 American Diabetes Association . Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 2007;  30 S42-S47
• 6 Alberti KG, Zimmet PZ. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.  Diabet Med. 1998;  15 539-553
• 7 Norhammar A, Tenerz A, Nilsson G. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.  Lancet. 2002;  359 2140-2144
• 8 Jindal RM. Posttransplant diabetes mellitus – a review.  Transplantation. 1994;  58 1289-1298
• 9 Hjelmesaeth J, Hartmann A, Kofstad J. Tapering off prednisolone and cyclosporine the first year after renal transplantation: The effect on glucose tolerance.  Nephrol Dial Transplant. 2001;  16 829-835
• 10 Davidson J, Wilkinson A, Dantal J. International Expert Panel. New-onset diabetes after transplantation: 2003 international consensus guidelines.  Proceedings of an international expert panel meeting. Barcelona, Spain 19 February 2003. Transplantation 2003 75 (Suppl 10) S3-S24
• 11 Kuypers DR, Claes K, Bammens B. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).  Nephrol Dial Transplant. 2008;  23 2033-2042
• 12 Rodrigo E, Fernández-Fresnedo G, Valero R. New-onset diabetes after kidney transplantation: risk factors.  J Am Soc Nephrol. 2006;  17 ((12 Suppl 3)) S291-S295
• 13 Mathew JT, Rao M, Job V. Post-transplant hyperglycaemia: a study of risk factors.  Nephrol Dial Transplant. 2003;  18 ((1)) 164-171
• 14 Kirkman MS, Shankar RR, Shankar S. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.  Diabetes Care. 2006;  29 2095-2101
• 15 Harris MI, Klein R, Welborn TA. Onset of NIDDM occurs at least 4–7 years before clinical diagnosis.  Diabetes Care. 1992;  15 815-819
• 16 Kanauchi M, Nakajima M, Saito Y. Pancreatic ß-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.  Metabolism. 2003;  52 476-481
• 17 Harris M, Eastman RC, Cowie CC. Comparison of diabetes diagnostic categories in the US. population according to the 1997 American Diabetes Association and 1980–1985 World Health Organization diagnostic criteria.  Diabetes Care. 1997;  20 1859-1862
• 18 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 1997;  20 1183-1197
• 19 Ceriello A. Postprandial Hyperglycemia and Diabetes Complications.  Diabetes. 2005;  54 1-7
• 20 Marchetti P, Navalesi R. The metabolic effects of cyclosporin and tacrolimus.  J Endocrinol Invest. 2000;  23 482-490
• 21 Wyzga J, Paczek L, Sañko-Resmer J. et al . kidney allograft recipients treated with calcineurin inhibitors.  Ann Transplant. 2007;  12 26-29
• 22 Saab S, Shpaner A, Zhao Y. et al . Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation.  Am J Transplant. 2006;  6 1890-1895
• 23 Muller V, Szabo AJ, Erdely A. et al . Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation.  Clin Exp Pharmacol Physiol. 2008;  35 574-579
• 24 Woodle ES, Alloway RR, Buell JF. et al . Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression.  Am J Transplant. 2005;  5 2740-2744

Correspondence